Dysoley Lek

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study

Rob W. van der Pluijm, Mallika Imwong, Nguyễn Hoàng Châu et al. · The Lancet Infectious Diseases · 2019 · 398 citations · Full text

Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study

William L. Hamilton, Roberto Amato, Rob W. van der Pluijm et al. · The Lancet Infectious Diseases · 2019 · 334 citations · Full text

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

Rob W. van der Pluijm, Rupam Tripura, Richard M. Hoglund et al. · The Lancet · 2020 · 270 citations · Full text

Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations

Valentine Duru, Nimol Khim, Rithea Leang et al. · BMC Medicine · 2015 · 203 citations · Full text

Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study

Mallika Imwong, Mehul Dhorda, Kyaw Myo Tun et al. · The Lancet Infectious Diseases · 2020 · 175 citations · Full text